List of Studies ( Metabolite:PA 32:2)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003913 | AN006426 | Altered Metabolomics and Inflammatory Transcriptomics in Human Bone Marrow Adipocytes After Acute High Calorie Diet and Acute Fasting | Blood | Human | MaineHealth Institute for Research | LC-MS/MS(Dir. Inf.) | |
| ST003913 | AN006426 | Altered Metabolomics and Inflammatory Transcriptomics in Human Bone Marrow Adipocytes After Acute High Calorie Diet and Acute Fasting | Bone marrow serum | Human | MaineHealth Institute for Research | LC-MS/MS(Dir. Inf.) | |
| ST003521 | AN005783 | Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii | Bacterial cells | Acinetobacter baumannii | Bacterial infection | Monash University | LC-MS |
| ST003114 | AN005102 | Lipidomics analyses in model membranes, isolated mitochondria and cellular systems to study how the local lipid environment affects BAX and BAK function during apoptosis. | Mitochondria | Human | Cancer | University of Cologne | LC-MS |
| ST003090 | AN005055 | Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B | Cultured cells | Mouse | Rutgers University | LC-MS | |
| ST003040 | AN004989 | MM.1S Myeloma tumor cells and tumors made by subcutaneously injecting 1M Luc+/GFP+ MM.1S cells treated with 50 μM BMS309403 and Vehicle (PBS with a matched concentration of 5% DMSO) | Cultured cells | Human | Cancer | MaineHealth Institute for Research | LC-MS |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Blood | Mouse | University of Kansas | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Brain | Mouse | University of Kansas | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Spinal cord | Mouse | University of Kansas | LC-MS | |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Fatty liver disease | University of Bonn | MS(Dir. Inf.) |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Obesity | University of Bonn | MS(Dir. Inf.) |
| ST002360 | AN003854 | Quantitative lipidomics of TFG-deficient B cells | Cultured cells | Mouse | University of Cologne | MS(Dir. Inf.) | |
| ST002140 | AN003502 | Mitochondrial respiration in B lymphocytes is essential for humoral immunity by controlling flux of the TCA cycle | B-cells | Mouse | University of Erlangen-Nürnberg | LC-MS/MS(Dir. Inf.) | |
| ST002057 | AN003349 | Distinct Human Hepatocyte Lipidomics Profiles for Nonalcoholic Steatohepatitis and In Vitro-Induced Steatosis | Cultured cells | Human | NASH | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001859 | AN003013 | dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin | Insect tissue | Fruit fly | VIB-KU Leuven | MS(Dir. Inf.) | |
| ST001859 | AN003014 | dTor affects the fat body lipidome via Nep1r1, Ctdnep1 and Lipin | Insect tissue | Fruit fly | VIB-KU Leuven | MS(Dir. Inf.) | |
| ST001442 | AN002410 | Human Optic Nerve Glaucoma and Control Lipidomes | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000915 | AN001490 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000114 | AN000193 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
